| Date | Topic | Speaker | Venue |
|---|---|---|---|
| January 22 2 to 3pm |
How can CRCs facilitate a clinical trial | Stephanie Tan (IMU) |
MD6 Seminar Room #09-01T |
| March 11 10 to 11am |
Roles of a Clinical Project Manager in a Project Lifecycle | Joanna Chang (IMU) |
MD6 Seminar Room #08-01T |
| April 8 10 to 11am |
The Similarities and Differences between Drug and Device Trials | Geraldine Seow (Johnson & Johnson) |
MD6 Seminar Room #08-01T |
| May 13 10 to 11am |
Data Management | Chan Peng (Tech Observer) |
MD6 Seminar Room #08-01T |
| June 10 10 to 11am |
Monitoring 101 | Lim Xiao Jing (Syneoshealth) |
MD6 Seminar Room #08-01T |
| July 8 10 to 11am |
Contracts 101 | Nick Ho (IQVIA) |
MD6 Seminar Room #08-01T |
| August 5 10 to 11am |
Marissa See (Bayer) |
MD6 Seminar Room #08-01T | |
| August 26 10 to 11am |
Proposal Development | Jessica Lee (IMU) |
MD6 Seminar Room #08-01T |
| September 16 10 to 11am |
Emotional Intelligence | Srinivas (IQVIA) |
MD6 Seminar Room #08-01T |
| October 14 10 to 11am |
Common Audit and Inspection Findings | Chua Wei Ting (Syneoshealth) |
MD6 Seminar Room #08-01T |
| November 11 10 to 11am |
The Common Difficulties / Difficulties Faced with Trial Set-up (The Most Memorable Experience of Speaker) |
Chan Lilian (IQVIA) |
MD6 Seminar Room #08-01T |
| Date | Topic | Speaker | Company |
|---|---|---|---|
| November 12, 2018 | How do the research team of the pharma decide which drug needs Post Marketing Study (PMS)? | Bernard Ng | Bayer |
| October 15, 2018 | Clinical Trial Monitoring and Informed Consent in Vulnerable Subjects (Updates) | Chua Wei Ting | Syneos Health |
| September 24, 2018 | 8 steps to Influence Others | Srinivas | IQVIA |
| September 10, 2018 | Common Audit and Inspection Findings | Michelle Ho | Syneos Health |
| August 27, 2018 | The Similarities and Differences between Early and Mid-late Phase Studies? What are the lessons learnt and what are the pitfalls of early phase studies? |
Chong Chew Lan | Celerion |
| August 13, 2018 | The Common Difficulties / Difficulties faced with Trial Set-up (The Most Memorable Experience of Speaker) |
Chan Lilian | IQVIA |
| June 18, 2018 | Understanding the Medtech Industry | Alok Mishra | Value Addition |
| May 21, 2018 | The Similarities and Differences between Drug and Device Trials | Geraldine Seow | Johnson & Johnson |
| April 09, 2018 | The Pros and Cons of the Increasing Needs for Remote Monitoring. | Nelson Wong | CSI Medical Research |
| March 12, 2018 | Regulatory Requirements for Clinical Trials (Investigator Initiated Trials and Industry Sponsored Trials) |
Lim Xiao Jing | Syneos Health |
| January 15, 2018 | Contracts between Sponsor and Site | Nick Ho | IQVIA |
| November 13, 2017 | Clinical Trial Monitoring and Informed Consent in Vulnerable Subjects | Chua Wei Ting | INC Research |
| October 16, 2017 | Updates to ICH GCP and Inspection Readiness | Michelle Ho | INC Research |
| September 11, 2017 | C2C- My Journey from Coordinator to CRA | Nelson Wong | Quintiles |
| August 14, 2017 | Expedited Safety Reporting Requirements and Notification of Serious Breach in Clinical Trials | Lim Xiao Jing | INC Research |
| July 24, 2017 | Taking Part in a Global Clinical Trial – How does my site get chosen, and How do I decide if this trial is right for me | Adeline Sng | Quintiles |
| July 10, 2017 | Differences and Similarities between Working at an Academic/Research Institution and Industry (Pharma/CRO) | Dr Foo Chuan Kit | Bayer |
| June 12, 2017 | Clinical Trials Management from CRO perspective | Chan Lilian Liang Pei Ling |
Quintiles |
